ACAD
ACADIA Pharmaceuticals Inc.When ACAD passed all Ten ChecksACADIA Pharmaceuticals Inc.
history · not a forecastOver the past 10 years, ACAD has passed all Ten Checks on 7 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +26.5% in Jan 2017, peaked day 13.
- Dec 2024+9.8% -3.9%
- Feb 2022+16.5% +1.9%
- Jan 2021-0.9% -14.5%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about ACAD’s checks
How many technical checks does ACAD pass right now?
As of the Aug 13, 2026 close, ACAD passes 5 of 10 fixed technical checks — the checks not passing: pulled back to support, holding above short-term average, stop distance within range, adequate stop room, quiet pullback volume.
Why does ACAD fail the "holding above short-term average" check?
ACAD closed at $28.38, 0.0% below its 9-day average ($28.39), so this momentum check fails. It passes again on a close above $28.39.
What price would change ACAD's check count?
The nearest flip level is "holding above short-term average" passes on a close above $28.39. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.